European Parliament Urges Increased Role For Generics And Biosimilars

Industry Welcomes Call For A ‘Greater Market Presence’ For Off-Patent Drugs

 
• By Dave Wallace

A report adopted by the European Parliament calling for measures to support a “greater market presence for generic and biosimilar medicines” has been welcomed by Medicines for Europe.

European parliament chamber
The European Parliament has adopted a report urging a greater presence for generics and biosimilars • Source: Alamy

More from Policy & Regulation

More from Generics Bulletin